Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study ; volume:11 ; number:1 ; day:28 ; month:9 ; year:2023 ; pages:1-14 ; date:12.2023
Intensive Care Medicine Experimental ; 11, Heft 1 (28.9.2023), 1-14, 12.2023
- Urheber
-
Sievert, Theodor
Didriksson, Ingrid
Spångfors, Martin
Lilja, Gisela
Blennow, Kaj
Zetterberg, Henrik
Frigyesi, Attila
Friberg, Hans
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40635-023-00547-x
- URN
-
urn:nbn:de:101:1-2024021210001983465067
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sievert, Theodor
- Didriksson, Ingrid
- Spångfors, Martin
- Lilja, Gisela
- Blennow, Kaj
- Zetterberg, Henrik
- Frigyesi, Attila
- Friberg, Hans
- SpringerLink (Online service)
Ähnliche Objekte (12)
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study
Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease
Fluid biomarkers in Alzheimer’s disease – current concepts
Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
Acute-Phase Neurofilament Light and Glial Fibrillary Acidic Proteins in Cerebrospinal Fluid Predict Long-Term Outcome After Severe Traumatic Brain Injury
Neurofilament light chain as neuronal injury marker – what is needed to facilitate implementation in clinical laboratory practice?
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
BACE1gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease